Results 21 to 30 of about 84,773 (249)

How does the immunogenicity of hepatitis B vaccine change over the years in childhood?

Human Vaccines & Immunotherapeutics, 2021
Hepatitis B is the leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. The incidence of HBV infection has significantly decreased with hepatitis B vaccination. Hepatitis B vaccine is administered to children at 0, 1 and
Gulsum Iclal Bayhan, Sidika Elif Balli, Hatice Demir, Zekiye Baydar   +3 more
doaj   +1 more source

PreHevbrio: the first approved 3-antigen hepatitis B vaccine

Expert Review of Vaccines, 2023
Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected.
Timo Vesikari, Joanne M Langley, Vlad Popovic, Francisco Diaz-Mitoma   +3 more
doaj   +1 more source

Hepatitis B infection among hemodialysis patients in Al-Jazirah State: a seroepidemiological survey

Current Issues in Pharmacy and Medical Sciences, 2023
Hemodialysis patients are more susceptible to HBV infection because they have low immunity and can be inflicted through an improperly sterilized machine or through a tainted blood transfusion.
Moglad Ehssan H. O., Mohammed Hajir E. E., Ali Hatim T.O.   +2 more
doaj   +1 more source

Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China

Human Vaccines & Immunotherapeutics, 2021
Recommendations promoted worldwide have suggested a period of protection lasting more than 20 years against hepatitis B (HB) following primary immunization. Starting in 1987, universal HB vaccinations were carried out in Long An County, Guangxi Province,
Zhigang Zheng, Guojian Li, Fuhui Liao, Lujuan Zhang, Xueyan Wang, Zhongliao Fang, Qinyan Chen, Huabin Liu, Liping Hu   +8 more
doaj   +1 more source

Trends of Advanced Chronic Liver Disease Among 17,711 Persons in Mongolia During Years 2015-2023. [PDF]

J Viral Hepat
ABSTRACT Chronic liver diseases cause a significant burden in Asia. This study aims to characterise the pattern and factors associated with advanced chronic liver disease (aCLD) in a large cohort from Mongolia, which has the highest rate of liver cancer globally.
Kamal H, Jargalsaikhan G, Enkhtaivan S, Bruce D, Lindahl K, Dashtseren B, Ulziibadrakh T, Batkhuu M, Bat-Ulzii P, Byambabaatar S, Aleman S, Dashdorj NB.   +11 more
europepmc   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study

Slovenian Journal of Public Health, 2022
In Slovenia national strategies to prevent hepatitis B virus (HBV) infection in children were introduced in the mid-nineties. The aim of the present study was to analyze the epidemiological characteristics of chronic hepatitis B infection in children in ...
Kmet Nina Grasselli, Poljak Mario, Zakotnik Breda, Matičič Mojca   +3 more
doaj   +1 more source

Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections [PDF]

, 2021
Background. Chronic hepatitis B and D virus (HBV/HDV) infections can cause cancer. Current HBV therapy using nucleoside analogues (NAs) is life-long and reduces but does not eliminate the risk of cancer.
Ahlén, G, Frelin, L, Jagya, N, Johansson, M, Maravelia, P, Meuleman, Philip, Ni, Y, Pasetto, A, Pater, L, Pérez, NC, Sällberg, M, Urban, S, Verch, G, Verhoye, Lieven   +13 more
core   +1 more source

Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now [PDF]

, 2015
Despite of the progress made in vaccine and antiviral therapy development, hepatitis B virus (HBV) infection remains a major health care problem. More than 240 million people are chronically infected worldwide showing differences in the severity of liver
Cuestas, María Luján, Eguibar, Nair, Gonzalez, Rodrigo Horacio, Nusblat, Alejandro David, Perazzo, Priscila   +4 more
core   +1 more source

Clinical, epidemiological and virological features of acute hepatitis B in Italy [PDF]

, 2015
Purpose To evaluate the association of hepatitis B virus (HBV) genotypes, basal core promoter (BCP)/precore (PC) and S gene mutations with the clinical-epidemiological characteristics of acute hepatitis B (AHB) in Italy.
Alessandro Remo Zanetti, Alfonso Mele, Andrea Mariano, Claudio Galli, Enea Spada, Gloria Taliani, Luisa Romanò, Maria Elena Tosti, Massimo Clementi, null null, Ornella Zuccaro   +10 more
core   +1 more source